COVID WTO IP Waiver
Total 8 Posts
At a budget hearing before a Subcommittee of the Senate Appropriations Committee today, U.S. Trade Representative Katherine Tai was asked questions on a number of trade policy issues, many of which focused on China.
The WTO's 12th Ministerial Conference concluded early in the morning of June 17 with a number of new decisions and declarations. In relation to China trade issues, one area of particular controversy had been whether China would be eligible to use a waiver of certain TRIPS Agreement rules on patents.
Republican Congressman Introduces Resolution Demanding Information on China's Access to Patents in any TRIPS Waiver
Congressman Adrian Smith (R-NE) introduced a Resolution on June 9 requesting that President Biden transmit information and documents on any TRIPS Waiver signed at the WTO, with a focus on China's access to intellectual property.
A draft text of the WTO TRIPS Waiver, which is designed to facilitate production of Covid-19 medicines in developing countries, has language that could exclude China from its scope. At a WTO meeting on Friday, China raised objections to specific aspects of that language.
U.S. Trade Representative Katherine Tai testified today before the House Ways and Means Committee, discussing various aspects of the Biden administration's trade policy agenda with members of the committee. We highlight here a number of comments made by Tai and the committee members on issues related to China trade
A report from an independent reporting initiative in Geneva indicates that as the United States and others work on a possible TRIPS Waiver, they may try to exclude China from benefitting.
The Senate Finance Committee held a hearing today on the Nominations of Maria Pagan to be a Deputy United States Trade Representative (Geneva Office) and Christopher Wilson to be USTR's Chief Innovation and Intellectual Property Negotiator (as well as Brent Neiman to be Deputy Under Secretary of the Treasury for